Cat. No.: DMM-001266
Status | Age | Sex |
---|---|---|
|
|
|
Model Overview | |
---|---|
Model Description | The Gcktm1Ts targeted mutation is lethal to homozygous mice perinatally, accompanied by severe hyperglycemia. Heterozygous mice have elevated blood glucose and impaired insulin secretion. |
Strain Name | B6.129S7-Gcktm1Ts/J |
Background Strain | 129S7/SvEvBrd-Hprt1 |
SPF | Yes |
Research Application | Diabetes |
Target Information | |
---|---|
Target Name | Gck |
Synonyms | FGQTL3, GK, GLK, Gls006, GLUKA, hexokinase 4, HHF3, HK4, HKIV, Hlb62, HXKP, LGLK, MODY2, PNDM1, RNGK2 |
Gene ID | 2645 |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.